Analyst Activity – HC Wainwright Initiates Coverage On IntelliPharmaCeutics Intl (NASDAQ:IPCI) With a Buy

Analyst Ratings For IntelliPharmaCeutics Intl (NASDAQ:IPCI)

Story continues below

Today, HC Wainwright initiated coverage on IntelliPharmaCeutics Intl (NASDAQ:IPCI) with a Buy with a price target of $2.50.

Some recent analyst ratings include

  • 1/19/2018-HC Wainwright initiated coverage with a Buy rating.
  • 9/26/2017-Mackie Upgrade from a “Hold” rating to a “” rating.
  • 4/18/2017-Aegis Reiterated Rating of Hold.


    Recent Trading Activity for IntelliPharmaCeutics Intl (NASDAQ:IPCI)
    Shares of IntelliPharmaCeutics Intl closed the previous trading session at 1.00 up +0.20 24.37% with 0.8801000118255615 shares trading hands.

    An ad to help with our costs